Burosumab-twza Subcutaneous and Morphine Immediate-Release Tablets and Capsules
Determining the interaction of Burosumab-twza Subcutaneous and Morphine Immediate-Release Tablets and Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Morphine injection
- Burosumab-twza Subcutaneous-Morphine Injection PF
- Burosumab-twza Subcutaneous-Morphine Long-Acting Tablets
- Burosumab-twza Subcutaneous-Morphine Oral Concentrate (20 mg/mL)
- Burosumab-twza Subcutaneous-Morphine Oral Solution
- Burosumab-twza Subcutaneous-Morphine Sulfate
- Morphine Immediate-Release Tablets and Capsules-Buspar
- Morphine Immediate-Release Tablets and Capsules-Buspar Dividose
- Morphine Immediate-Release Tablets and Capsules-Buspirone
- Morphine Immediate-Release Tablets and Capsules-Buspirone Hydrochloride
- Morphine Immediate-Release Tablets and Capsules-Busulfan
- Morphine Immediate-Release Tablets and Capsules-Busulfan Concentrate Injection